Elicera Therapeutics AB's total assets for Q4 2025 were kr27.42M, a decrease of -26.48% from the previous quarter. DE:8E8 total liabilities were kr4.06M for the fiscal quarter, a -41.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.